SCHEMBL30945715

SCHEMBL30945715

Cc1ccc2c(c1)C1CN(C)CCC1N2C(=O)/C=C/c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.72
▸ HTR6 P50406 2/20 0.66
▸ ALDH1A1 P00352 6/20 0.59
▸ MAPK1 P28482 2/20 0.59
▸ MAPT P10636 5/20 0.56
▸ LMNA P02545 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ MCL1 Q07820 1/20 0.55
▸ HTT P42858 2/20 0.55
▸ F2 P00734 1/20 0.55
▸ GAA P10253 2/20 0.54
▸ APOBEC3A P31941 1/20 0.54
▸ APOBEC3G Q9HC16 1/20 0.54
▸ KDM4E B2RXH2 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30945708 0.90 SMN1; SMN2 (0.73) SMN1; SMN2HTR6ALDH1A1MAPK1MAPT
SCHEMBL30945669 0.88 SMN1; SMN2 (0.70) SMN1; SMN2HTR6ALDH1A1MAPK1MAPT
SCHEMBL30945695 0.87 MAPT (0.67) SMN1; SMN2HTR6ALDH1A1MAPK1MAPT
SCHEMBL30945711 0.84 SMN1; SMN2 (1.00) SMN1; SMN2HTR6ALDH1A1MAPK1MAPT
SCHEMBL29223991 0.82 ALDH1A1 (0.67) SMN1; SMN2HTR6ALDH1A1MAPK1MAPT
SCHEMBL30945658 0.82 SMN1; SMN2 (0.65) SMN1; SMN2HTR6ALDH1A1MAPK1MAPT
SCHEMBL12868610 0.82 ALDH1A1 (0.70) HTR6ALDH1A1MAPK1MAPTLMNA
SCHEMBL30095965 0.81 SMN1; SMN2 (0.61) SMN1; SMN2HTR6ALDH1A1MAPK1MAPT
SCHEMBL30095908 0.81 SMN1; SMN2 (0.61) SMN1; SMN2HTR6ALDH1A1MAPK1MAPT
SCHEMBL13368729 0.80 HTR6 (1.00) SMN1; SMN2HTR6ALDH1A1MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS CULLGEN (SHANGHAI), INC. (CN) 2024-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS DCAF1, DDB1, CUL4A SMN1; SMN2 3151/4885HTR6 4628/4885ALDH1A1 2985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback